## **Core Concept**
Etanercept is a biologic medication used in the treatment of rheumatoid arthritis. It belongs to a class of drugs known as tumor necrosis factor (TNF) inhibitors. TNF is a cytokine involved in systemic inflammation and is a key mediator in the pathogenesis of rheumatoid arthritis.

## **Why the Correct Answer is Right**
The correct answer, , indicates that etanercept acts by inhibiting tumor necrosis factor-alpha (TNF-α). Etanercept is a fusion protein that combines part of the TNF receptor with the Fc portion of IgG1. By binding to TNF-α, etanercept prevents TNF-α from interacting with its cell surface receptor, thereby reducing inflammation and slowing disease progression in rheumatoid arthritis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because etanercept does not primarily act by inhibiting interleukin-1 (IL-1), although IL-1 is another cytokine involved in inflammation.
- **Option B:** This option is incorrect as etanercept's mechanism does not primarily involve the inhibition of cyclooxygenase (COX) enzymes, which are targets for nonsteroidal anti-inflammatory drugs (NSAIDs).
- **Option C:** This option is incorrect because etanercept does not act by stimulating the production of anti-inflammatory cytokines.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that patients on TNF inhibitors like etanercept are at increased risk of infections, including reactivation of latent tuberculosis (TB). Therefore, screening for TB is recommended before initiating therapy with etanercept.

## **Correct Answer:** . Etanercept